Filament Health and Jaguar Health's Joint Venture Completes Successful Import of Coca Leaf for Psychedelic Research
Portfolio Pulse from Benzinga Newsdesk
Filament Health Corp. and Jaguar Health, Inc. have successfully completed an import of coca leaf to Filament's Metro Vancouver research and development facility. The import was authorized by the Peruvian Health Authority and acquired from the Empresa Nacional de la Coca. The imported leaves will be used for initial research purposes to look at neuropsychiatric indications.
September 21, 2023 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Filament Health's successful import of coca leaf for research could potentially lead to new product developments.
The successful import of coca leaf allows Filament Health to conduct research that could potentially lead to the development of new products. This could have a positive impact on the company's stock in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jaguar Health's joint venture with Filament Health could potentially lead to new product developments.
Jaguar Health's joint venture with Filament Health and the successful import of coca leaf could potentially lead to the development of new products. This could have a positive impact on the company's stock in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 70